A recent randomized controlled trial of varenicline (Chantix) combined with psychological support has significantly increased the chance of quitting smoking for 300 smokers with type 2 diabetes mellitus
Quitting smoking can reduce cardiovascular and kidney failure risks. However, it can lead to side effects such as weight gain. A scoping review conducted by a pool of European researchers revealed a lack of data on the metabolic effects of smoking and smoking cessation in diabetes. Healthcare professionals should not assume that cessation of smoking will improve metabolic parameters in patients with diabetes.
Yesterday, the Italian Ministry of Health released new data on smoking prevalence: there are 800000 more smokers in the country than in 2019. Rates increased especially among women and young people. The report found that also the numbers of the users of heated tobacco products and electronic cigarettes is rising. “An expected disaster, partly anticipated by our data published in 2020 and obtained thanks to a study conducted during the acute phase of Covid-19 pandemic. Since then, no prevention policies, no answers from the Italian health authorities. Reporting a disaster is not enough: we need to come up with alternative and effective solutions”. Stated professor Riccardo Polosa, founder of the CoEHAR, who opened the first National Conference on Tobacco Harm Reduction.
On 31 May 2022, to celebrate the World No Tobacco Day, CoEHAR, the Center of Excellence for the acceleration of Harm Reduction of the University of Catania, will host the first National Conference on Tobacco Harm Reduction “Risks and benefits of Combustion free products".
Overall, the study authors believe that smoking cessation has a positive effect on asthmatic patients' respiratory health: the longer you abstain from smoking, the better your asthma symptoms will be. Gradually, patients with asthma gain a higher quality of life as their exacerbations decrease.
The Foundation for a Smoke Free World (FSFW) will host a free 60-minute public economics webinar to discuss the latest news regarding electronic nicotine delivery systems. Join the meeting Thursday, May 12, 2022 at 9.00AM US EST
The results of the study published by the prestigious scientific magazine “Drug Testing & Analysis” showed no contaminants in all e-liquids and a metal content below the levels permitted by WHO for drinking-waters
CoEHAR researchers investigated for the first time the relationship between biochemically-verified smoking status and SARS-CoV-2 infection in a large population study. The study “The impact of laboratory-verified smoking on SARS-CoV-2 infection: Results from the Troina sero-epidemiological survey”, found that the prevalence of SARS-CoV-2 antibody positivity were reduced in smokers compared to former and never smokers (19.8% vs. 31%)
CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania
Under the leadership of CoEHAR, a team of international researchers, examined the 24 most frequently cited vaping studies published in medical journals. The findings are shocking: almost all of these studies were found to be methodologically flawed; they lacked a clear hypothesis, used inadequate methodology, failed to collect data relevant to the study objectives, and did not correct for obvious confounding factors.
We will send you direct emails, without intermediary services, you can withdraw any time.
Copyright 2021 – Center of Excellence for the acceleration of Harm Reduction. All rights reserved.